date	description	size	author		document
11.04.13	Plenary Session I: ‘A look ahead’	33	blankin		Plenary-Session-I
11.04.13	Frequency of Huntington Disease - Greater than you think	9 kB	blankin		ehdn-2012-hayden-empty-file
11.04.13	What are we really looking for in an HD drug?	9 kB	blankin		ehdn-2012-sampaio-empty-file
11.04.13	Care, coping and research in HD – the earlier the better!	9 kB	blankin		ehdn-2012-duerr-empty-file
11.04.13	Plenary Session II: ‘Frontiers in biology and their relevance to Huntington’s disease’	33	blankin		Plenary-Session-II
11.04.13	Longevity pathways and their relevance to human disease	9 kB	blankin		ehdn-2012--aguilaniu-empty-file
11.04.13	RNA toxicity in poly-Q disorders	3.3 MB	blankin		ehdn-2012-krzyzosiak
11.04.13	Post-translational modifications and proteolysis of huntingtin	9 kB	blankin		ehdn-2012-truant-empty-file
11.04.13	Plenary Session III: ‘Science practice at EHDN’	33	blankin		Plenary-Session-III
11.04.13	Scientific strategy of EHDN	126 kB	blankin		ehdn-2012-bronzova
11.04.13	Juvenile HD Working Group	441 kB	blankin		ehdn-2012-quarrell
11.04.13	Advanced HD Working Group	9 kB	blankin		ehdn-2012-youssov-empty-file
11.04.13	Animal studies on the effects of physiotherapy	9 kB	blankin		ehdn-2012-brooks-empty-file
11.04.13	Human physiotherapy studies	9 kB	blankin		ehdn-2012-busse-empty-file
11.04.13	Short Communications I: 'Scientific Presentations: 10’ and 5’ questions – selected from submissions'	33	blankin		Short-Communications-I
11.04.13	Default-mode network changes in preclinical Huntington´s disease	9 kB	blankin		ehdn-2012-orth-empty-file
11.04.13	Longitudinal functional and connectivity changes during working memory performance in HD	9 kB	blankin		ehdn-2012-georgiou-karistianis-empty-f...
11.04.13	Better global and cognitive functioning for choreatic compared to hypokinetic- rigid HD	9 kB	blankin		ehdn-2012-t-hart-empty-file
11.04.13	Critical consideration of the criteria for the motor diagnosis of HD	9 kB	blankin		ehdn-2012-paulsen-empty-file
11.04.13	Plenary Session IV: Keynote presentations	33	blankin		Plenary-Session-IV
11.04.13	Update on stem cell research: clinical potentials	9 kB	blankin		ehdn-2012-brundin-empty-file
11.04.13	Cognitive alterations in HD	9 kB	blankin		ehdn-2012-stout-empty-file
11.04.13	Roundup I	33	blankin		Roundup-I
11.04.13	Lessons of the day	9 kB	blankin		ehdn-2012-wild-empty-file
11.04.13	Breakfast teaching courses Sat	33	blankin		Breakfast-teaching-courses-sat
11.04.13	Clinical management of Huntington’s disease	9 kB	blankin		ehdn-2012-nance-empty-file
11.04.13	Differential diagnosis of chorea	9 kB	blankin		ehdn-2012-walker-empty-file
11.04.13	Behavioral assessment and management of behavioral issues	9 kB	blankin		ehdn-2012-anderson-empty-file
11.04.13	Training on HD assessments including HD-CC	9 kB	blankin		ehdn-2012-craufurd-empty-file
11.04.13	Training on HD assessments including HD-CC	9 kB	blankin		ehdn-2012-reilmann-empty-file
11.04.13	Training on HD assessments including HD-CC	9 kB	blankin		ehdn-2012-j-thompson-empty-file
11.04.13	Training on HD assessments including HD-CC	9 kB	blankin		ehdn-2012-quarrell-empty-file
11.04.13	Plenary Session V: ‘Understanding and manipulating the pathogenic process in Huntington’s disease’	33	blankin		Plenary-Session-V
11.04.13	Huntingtin	7.9 MB	blankin		ehdn-2012-cattaneo
11.04.13	Post-translational modifications of huntingtin	9 kB	blankin		ehdn-2012-saudou-empty-file
11.04.13	Stem cells for basic research on HD	1.8 MB	blankin		ehdn-2012-ellerby
11.04.13	Stem cells for basic research on HD	9 kB	blankin		ehdn-2012-l-thompson-empty-file
11.04.13	Plenary Session VI: Keynote presentations	33	blankin		Plenary-Session-VI
11.04.13	Keynote presentations	9 kB	blankin		ehdn-2012-aronin-empty-file
11.04.13	Updates on lowering huntingtin (htt) levels	9 kB	blankin		ehdn-2012-davidson-empty-file
11.04.13	Short communications II: Scientific presentations	33	blankin		Short-communications-II
11.04.13	HDAC4 interacts with huntingtin and HDAC4 reduction decreases cytoplasmic aggregation and rescues synaptic dysfunction in HD mouse models	9 kB	blankin		ehdn-2012-bates-empty-file
11.04.13	Aging pathway and poly-Q neurotoxicity	656 kB	blankin		ehdn-2012-nollen
11.04.13	NeuroNet and its potential for the study of neurodegeneration	9 kB	blankin		ehdn-2012-wanker-empty-file
11.04.13	Phenotyping neural networks in an ovine model of HD	9 kB	blankin		ehdn-2012-perentos-empty-file
11.04.13	Plenary Session VII: ‘Therapeutic development programs in Huntington’s Disease’	33	blankin		Plenary-Session-VII
11.04.13	Overview of CHDI drug development programs	3.5 MB	blankin		ehdn-2012-pacifici
11.04.13	Htt lowering: Medtronic-Alnylam/Isis/CHDI	9 kB	blankin		ehdn-2012-mcdonald-empty-file
11.04.13	Sirt1-inhibition: SienaBiotech	9 kB	blankin		ehdn-2012-caricasole-empty-file
11.04.13	PDE-10-inhibition: Pfizer	9 kB	blankin		ehdn-2012-schmidt-empty-file
11.04.13	PDE-4-inhibition: GSK	9 kB	blankin		ehdn-2012-gray-empty-file
11.04.13	Bupropion: ACTION-HD	9 kB	blankin		ehdn-2012-priller-empty-file
11.04.13	PREQUEL EHDN	9 kB	blankin		ehdn-2012-ross-empty-file
11.04.13	Reach2HD PBT2	9 kB	blankin		ehdn-2012-stout-empty-file
11.04.13	Dopaminergic stabilization in HD: pridopidine	9 kB	blankin		ehdn-2012-kieburtz-empty-file
08.04.13	Plenary Session VIII: EHDN Business Meeting	33	blankin		Plenary-Session-VIII
08.04.13	EHDN Update - EC elections, SBAC elections, Structure of EHDN	9 kB	blankin		ehdn-2012-landwehrmeyer-empty-file
08.04.13	Presentation of the HDYO website	2.5 MB	blankin		ehdn-2012-ellison
08.04.13	Standards of Care	9 kB	blankin		ehdn-2012-rea-empty-file
08.04.13	Roundup II	33	blankin		Roundup-II
08.04.13	Lessons of the day	9 kB	blankin		ehdn-2012-wild-empty-file
08.04.13	Breakfast teaching courses Sun	33	blankin		Breakfast-teaching-courses-sun
08.04.13	Drug discovery and development process	9 kB	blankin		ehdn-2012-kwak-empty-file
08.04.13	Training on HD assessments including HD-CC	9 kB	blankin		ehdn-2012-craufurd-empty-file
08.04.13	Training on HD assessments including HD-CC	9 kB	blankin		ehdn-2012-reilmann-empty-file
08.04.13	Training on HD assessments including HD-CC	9 kB	blankin		ehdn-2012-thompson-empty-file
08.04.13	Training on HD assessments including HD-CC	9 kB	blankin		ehdn-2012-quarrell-empty-file
08.04.13	HD for Basic Scientists	9 kB	blankin		ehdn-2012-landwehrmeyer-empty-file
08.04.13	Common issues/problems/inconsistencies in HD assessments	9 kB	blankin		ehdn-2012-ferreira-empty-file
08.04.13	Plenary Session IX: ‘Tools and outcome to monitor disease progression and response to therapy’	33	blankin		Plenary-Session-IX
08.04.13	Brain imaging as a potential marker for HD (PET)	9 kB	blankin		ehdn-2012-varrone-empty-file
08.04.13	MRI as a potential marker for HD	971 kB	blankin		ehdn-2012-scahill
08.04.13	Defining predictors of disease	1.9 MB	blankin		ehdn-2012-tabrizi
08.04.13	New assessment tools (cognitive batteries)	9 kB	blankin		ehdn-2012-bachoud-levi-empty-file
08.04.13	New assessment tools (cognitive batteries)	9 kB	blankin		ehdn-2012-stout-empty-file
08.04.13	REGISTRY and Enroll-HD	9 kB	blankin		ehdn-2012-landwehrmeyer-empty-file
08.04.13	Poster Awards	9 kB	blankin		ehdn-2012-landwehrmeyer-empty-file
08.04.13	Roundup III	33	blankin		Roundup-III
08.04.13	Progress in HD research and HD advocacy: a personal view	9 kB	blankin		ehdn-2012-sabine-empty-file
08.04.13	EHA meeting	33	blankin		EHA-meeting
08.04.13	Falling in love, staying in love	89 kB	blankin		eha-2012-mol
08.04.13	Oral Presentations	33	blankin		Oral-Presentations
08.04.13	Juvenile Huntington's disease	662 kB	blankin		a03-juvenile-hd
08.04.13	Default-mode network changes in preclinical Huntington’s disease	1.5 MB	blankin		a04-default-mode-network-changes
08.04.13	Better global and cognitive functioning for choreatic compared to hypokinetic-rigid Huntington’s disease	380 kB	blankin		a06-better-global-and-cognitive-functi...
08.04.13	Critical consideration of the criteria for the motor diagnosis of Huntington disease	387 kB	blankin		a07-critical-consideration-criteria-mo...
08.04.13	Defining predictors of disease	2.0 MB	blankin		a11-induced-pluripotent-stem-cells

Folder contains 87 documents.